Abiopharma

🔍 Ratner Elena (Director)

Company: Ernexa Therapeutics Inc. (ERNA)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 5,944 shares of Stock Option (Right to buy) at $4.57 per share (Derivative)
  Date: 2026-08-31 | Code: A | Expires: 2036-08-31 | equity_swap_involved: 0 | shares_owned_after: 5,944.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.